Mostrar el registro sencillo del ítem
dc.contributor.author | Ugarte-Gil, Manuel Francisco | |
dc.contributor.author | Gamboa-Cardenas, Rocio Violeta | |
dc.contributor.author | Reátegui-Sokolova, Cristina | |
dc.contributor.author | Pimentel-Quiroz, Victor Román | |
dc.contributor.author | Medina, Mariela | |
dc.contributor.author | Elera-Fitzcarrald, Claudia | |
dc.contributor.author | Rodriguez-Bellido, Zoila | |
dc.contributor.author | Pastor-Asurza, Cesar Augusto | |
dc.contributor.author | Perich-Campos, Risto Alfredo | |
dc.contributor.author | Alarcón, Graciela S. | |
dc.coverage.spatial | Departamento de Reumatología, Hospital Guillermo Almenara Irigoyen, Lima, Peru. | |
dc.date.accessioned | 2023-03-23T15:49:32Z | |
dc.date.available | 2023-03-23T15:49:32Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/13258 | |
dc.description.abstract | Objective To determine the possible predictive value of self-efficacy on health-related quality of life (HRQoL) in patients with SLE. Methods Patients with SLE from the Almenara Lupus Cohort were included. Self-efficacy was ascertained with the six domains from the Patient-Reported Outcomes Measurement Information System (PROMIS) self-efficacy for managing chronic conditions. For PROMIS domains, a score of 50 is the average for a clinical population (people with a chronic condition), a higher score indicates that the respondent has greater self-efficacy. HRQoL was ascertained with the physical and mental component summary (PCS and MCS) measures of the Short-Form 36 (SF-36). Generalised estimating equations were performed, using as outcome the PCS or MCS in the subsequent visit, and the self-efficacy domain in the previous visit; multivariable models were adjusted for possible confounders. The confounders were measured in the same visit as the self-efficacy domain. Results Two-hundred and nine patients for a total of 564 visits were included; 194 (92.8%) patients were women and mean age at diagnosis was 36.4 (14.0) years. In the multivariable models, a better PCS was predicted by a better self-efficacy for managing symptoms, managing medications and treatments and managing social interactions and general self-efficacy; a better MCS was predicted by a better self-efficacy for managing daily activities, managing symptoms, managing medications and treatments and managing social interactions. Conclusion A better self-efficacy is predictive of subsequent better HRQoL, even after adjustment for possible confounders. These results should encourage clinicians to develop strategies to improve self-efficacy in patients with SLE. | en_US |
dc.language.iso | eng | |
dc.publisher | BMJ Publishing Group | |
dc.relation.ispartofseries | Lupus Science and Medicine | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | quality of life | en_US |
dc.subject | HRQoL | en_US |
dc.subject | patients | en_US |
dc.subject | systemic lupus erythematosus | en_US |
dc.subject | Almenara Lupus Cohort | en_US |
dc.subject.mesh | Calidad de Vida | |
dc.subject.mesh | Lupus Eritematoso Sistémico | |
dc.title | A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: Data from the Almenara Lupus Cohort | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1136/lupus-2022-000874 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.03 | |
dc.relation.issn | 2053-8790 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |